Eusol Biotech Co.,Ltd. (6652.TWO)
TWD 6.1
(0.16%)
TWD 6.1
(0.16%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -51.61 Million TWD | -181.88% |
| 2022 | -18.31 Million TWD | 85.15% |
| 2021 | -123.3 Million TWD | -8.38% |
| 2020 | -113.77 Million TWD | -6.07% |
| 2019 | -107.25 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -7.86 Million TWD | 52.98% |
| 2024 Q2 | -7.86 Million TWD | 0.0% |
| 2023 Q4 | -16.72 Million TWD | 0.0% |
| 2023 Q3 | -16.72 Million TWD | -84.09% |
| 2023 FY | -51.61 Million TWD | -181.88% |
| 2023 Q2 | -9.08 Million TWD | 0.0% |
| 2023 Q1 | -9.08 Million TWD | -201.83% |
| 2022 Q3 | 8.92 Million TWD | 0.0% |
| 2022 FY | -18.31 Million TWD | 85.15% |
| 2022 Q4 | 8.92 Million TWD | 0.0% |
| 2021 FY | -123.3 Million TWD | -8.38% |
| 2020 FY | -113.77 Million TWD | -6.07% |
| 2019 FY | -107.25 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 120.562% |
| Level Biotechnology Inc. | 62.9 Million TWD | 182.049% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 73.506% |
| GlycoNex Incorporation | -178.36 Million TWD | 71.063% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 68.958% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 95.068% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -383.177% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 69.29% |
| Visgeneer Inc. | -19.58 Million TWD | -163.48% |
| Neith Corporation | -40.03 Million TWD | -28.926% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 78.318% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 95.55% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -753.531% |
| Enimmune corporation | -223.74 Million TWD | 76.932% |
| TaiRx, Inc. | -212.29 Million TWD | 75.688% |
| CHO Pharma, Inc. | -306.08 Million TWD | 83.138% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 203.759% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 18.489% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 109.569% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 326.452% |
| Lukas Biomedical Inc. | -47.35 Million TWD | -8.996% |
| RBC Bioscience Corporation | 6.43 Million TWD | 902.691% |
| NaviFUS Corp. | -65.72 Million TWD | 21.476% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 92.498% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -38.875% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 16.131% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 6.225% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 29.572% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 43.966% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 66.984% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 171.289% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 24.276% |
| Lin BioScience, Inc. | -687.19 Million TWD | 92.489% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 0.326% |
| AP Biosciences Inc | -339.29 Million TWD | 84.788% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 108.249% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 118.78% |
| EirGenix Inc. | -915.2 Million TWD | 94.361% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 710.371% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 92.441% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -35.212% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 20.159% |
| VBI | -6.6 Million TWD | -681.897% |
| BiOptic Inc. | 37.74 Million TWD | 236.734% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 41.408% |
| Sinew Pharma Inc. | -170.92 Million TWD | 69.803% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 139.501% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 90.805% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 10.937% |
| Intech Biopharm Corporation | -337.98 Million TWD | 84.729% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 96.069% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 69.761% |
| TCI GENE Inc. | 11.67 Million TWD | 542.157% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 59.534% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 82.581% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 76.271% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 610.01% |
| PharmaEngine, Inc. | 274.65 Million TWD | 118.792% |
| Savior Lifetec Corporation | 30.03 Million TWD | 271.871% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 137.748% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 58.824% |
| Acepodia, Inc. | -817.31 Million TWD | 93.685% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 89.433% |